Eating on GLP-1 drugs: the jab kills your appetite. Your muscles pay if you let it.
Ozempic, Wegovy and Mounjaro make you eat less. That's the point. The catch is that eating less, badly, costs muscle, and the drugs don't come with a menu. This is the menu.
The short version
- What it is
- How to eat while on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound): small meals, protein first, plenty of water and fibre.
- Good for
- Keeping muscle, fewer stomach problems, getting enough nutrients from much less food.
- Bad at
- Replacing your doctor. Or keeping the weight off once the jabs stop.
- Evidence
- Moderate. Strong for the drugs, thinner for the diet around them.
- Our take
- The drug does the hunger part. Your plate does the muscle part. Nobody gets to skip the plate.
What eating on Ozempic actually is
GLP-1 drugs copy a gut hormone that tells your brain you've eaten. Semaglutide (sold as Ozempic for diabetes and Wegovy for weight) and tirzepatide (Mounjaro, Zepbound, which also copies a second hormone called GIP) turn the volume on hunger way down.
They work. In the big semaglutide trial, people lost about 15% of their body weight in 68 weeks, against about 2% on placebo.1 On the top dose of tirzepatide it was about 21% in 72 weeks.2 No diet in history has numbers like that.
So "eating on GLP-1" isn't a diet that makes you lose weight. The drug does that. It's a way of eating that makes sure the weight you lose is mostly fat, that you don't spend the year feeling sick, and that you get enough protein, vitamins and minerals from a lot less food.
How it works in your body
GLP-1 drugs slow down how fast your stomach empties and act on the appetite centres in your brain. You feel full sooner and stay full longer. Food noise, that constant background chatter about the fridge, goes quiet for many people.
Here's the problem. When you suddenly eat 30–40% less, your body doesn't only burn fat. It also breaks down muscle, especially if you eat little protein and don't use your muscles. In trials with body scans, the share of weight lost as lean mass ranged from about 15% to as much as 40–60% of the total.5 Lean mass isn't only muscle (it includes water and organs), but muscle is the part you really don't want to lose, because it's what keeps you strong, mobile and burning energy as you age.
A joint advisory from four US obesity and nutrition societies puts it plainly: during GLP-1 treatment, protecting muscle and bone with strength training and a proper diet, avoiding nutrient gaps and managing stomach side effects should be standard care.4
What you eat, what you don't
Eat
- Protein at every meal, first: fish, eggs, chicken, tofu, Greek yoghurt, cottage cheese
- Beans, lentils, chickpeas (protein and fibre in one)
- Cooked vegetables, soups, stews: easy on a slow stomach
- Small portions of oats, brown rice, wholegrain bread
- Water, all day. Plain or with lemon
- Berries, kiwi, a banana if you're nauseous
Forget it
- Greasy, fried food: the fastest way to throw up on these drugs
- Big meals, even "healthy" ones
- Soft drinks and fizzy drinks that bloat you
- Sweets and pastries filling your three small bites
- Skipping meals because you're not hungry
- Eating late and lying down straight after
Alcohol on GLP-1 drugs
If at all, small and slow
- One small glass of dry wine with food
- A spirit with soda water and lime, with food
- Alcohol-free beer, if it doesn't bloat you
Skip it
- Drinking on an empty stomach
- Beer, cider, sweet cocktails (bloating plus sugar)
- Several drinks in one evening
- Any alcohol while you're nauseous or throwing up
50 Club: not on this one. Your food intake is already small, so every empty calorie pushes out protein you need.
Many people on these drugs find they want less alcohol anyway. If you take insulin or a sulfonylurea as well, alcohol adds to the risk of low blood sugar: ask your doctor. All the details are in our alcohol guide.
What it's good for, with proof
Keeping the muscle while the fat goes
The drugs don't decide what you lose. You partly do. Protein plus strength training is the best-tested way to build and keep muscle: in a meta-analysis of 49 trials, extra protein added to resistance training increased muscle mass and strength, with the benefit levelling off at around 1.6 g of protein per kg of body weight a day.8 Those trials weren't in GLP-1 users, so take it as the best guide we have, not a GLP-1 rule. The GLP-1 advisory recommends exactly this combination.4
Fewer stomach problems
Nausea, constipation, diarrhoea and reflux are the most common side effects, mostly early on and after dose increases.7 Clinical advice to manage them is very practical: eat smaller meals, stop when you feel full, cut fatty and fried food, drink enough, and don't eat right before lying down.7 No magic, just less food in a slower stomach.
Getting enough from less
Eating far less food for a year means eating far less iron, calcium, fibre and vitamins too. The advisory flags nutrient deficiencies as a real risk and calls for checking what people actually eat, not just what they weigh.4 When every bite counts, the bite should be a good one.
The uncomfortable truth
"Once the weight's off, I'll stop the jab and I'm done." The trial data say otherwise. When people in the semaglutide trial stopped treatment, they regained about two-thirds of the weight they had lost within a year.3 Their blood pressure and blood sugar improvements faded too.
That isn't a moral failure. The hunger comes back because the drug stops working when you stop taking it. It's the strongest argument for building real eating habits while you're on the drug, so that when the volume on hunger goes back up, the habits are still there.
"I'm hardly hungry, so I can just eat whatever little I want." You can. You'll also lose more muscle and feel worse. A few biscuits a day is a lot of nothing.
The risks
- Muscle loss. The big one for anyone older or already not very strong.5 Lift something heavy at least twice a week and eat your protein.
- Gallbladder problems. In a meta-analysis of 76 trials, GLP-1 drugs raised the risk of gallstones and gallbladder inflammation, more so at the higher doses used for weight loss.6 Fast weight loss itself is part of the reason. Pain in the upper right belly after meals: see a doctor.
- Dehydration. You eat less, so you drink less without noticing, and vomiting or diarrhoea make it worse. That can strain your kidneys.7
- Low blood sugar. Not usually a problem on its own, but a real risk combined with insulin or sulfonylureas. Your doses may need changing.
- Eating too little. Some people slide to a few hundred calories a day without trying. That's not discipline, that's undernutrition.
Allergies: watch the staples
The protein-first approach leans on a few major allergens. Swap them, don't just drop them, or your protein crashes.
| Staple | Allergen (EU list of 14)9 | Swap |
|---|---|---|
| Greek yoghurt, cottage cheese, skyr | Milk | Soy yoghurt, tofu, eggs |
| Eggs | Eggs | Fish, chicken, tofu |
| Salmon, tuna, white fish | Fish | Chicken, eggs, lentils |
| Tofu, tempeh, soy milk | Soy | Lentils, chickpeas, eggs |
| Protein shakes (whey, soy) | Milk or soy | Pea protein; check the label |
| Oats, wholegrain bread | Cereals containing gluten | Quinoa, buckwheat, brown rice |
| Nut butter on toast | Peanuts, tree nuts | Sunflower or pumpkin seed butter |
Don't do GLP-1 eating without your doctor if you…
- got the drug without a prescription or from an online shop that never asked about your health
- are pregnant, trying to get pregnant or breastfeeding
- have ever had an eating disorder
- also take insulin or sulfonylureas
- have had pancreatitis or gallbladder problems
- are over 65 or already losing strength
Healthen me asks about all of these and gives you a different plan if any apply.
How we use GLP-1 eating in your plan
If you tell us you're on a GLP-1 drug, you get your own gentle track. No fasting: the drug already cuts your intake, and long fasts on top make undernutrition and muscle loss more likely.
Your plan gets smaller plates, protein first at every meal (the same idea as our high-protein building block), cooked vegetables, soups and stews, and plenty of water. If you're over 50, the muscle rules from eating over 50 kick in as well.
We also tell you, clearly and more than once, to keep your doctor in the loop. We don't adjust medication. Ever.
This article is general information, not medical advice. If you have a medical condition or take medication, talk to your doctor before changing how you eat.
Sources
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine 2021;384(11):989–1002. doi.org/10.1056/NEJMoa2032183
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine 2022;387(3):205–216. doi.org/10.1056/NEJMoa2206038
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism 2022;24(8):1553–1564. doi.org/10.1111/dom.14725
- Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. American Journal of Clinical Nutrition 2025;122(1):344–367. doi.org/10.1016/j.ajcnut.2025.04.023
- Neeland IJ et al. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism 2024;26 Suppl 4:16–27. doi.org/10.1111/dom.15728
- He L et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials. JAMA Internal Medicine 2022;182(5):513–519. doi.org/10.1001/jamainternmed.2022.0338
- Wharton S et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgraduate Medicine 2022;134(1):14–19. doi.org/10.1080/00325481.2021.2002616
- Morton RW et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine 2018;52(6):376–384. doi.org/10.1136/bjsports-2017-097608
- Regulation (EU) No 1169/2011 on food information to consumers, Annex II (the 14 allergens). eur-lex.europa.eu/eli/reg/2011/1169/oj